NL-OMON27548暂停不适用
Smellprints in lung Cancer; the role of ENose in diagnosis and Treatment (SCENT):part 3. Acute effects on smellprints of chemotherapy in patients with lung cancer.
MCL, Leeuwarden0 个研究点目标入组 75 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 暂停
- 发起方
- 入组人数
- 75
研究概览
简要总结
/A
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Informed consent is obtained;
- •2. newly diagnosed adenocarcinoma or squamous cell carcinoma stage IIIA, IIIB or IV or small cell lung cancer);
排除标准
- •1. Previous chemotherapy;
- •2. unable to evaluate response with the RECIST criteria;
研究者
相似试验
暂停
不适用
eNose in Colorectal Cancer.Colorectal CancerNL-OMON24427Medical Centre LeeuwardenLeeuwardenthe Netherlands20
暂停
不适用
SCENT 1. Differences in smellprints between patients with lung cancer and breast cancer.eNose (electronische neus)smell-print (geurprofiel)lung cancer (longkanker)breast cancer (borstkanker)exhaled breath (uitademingslucht)NL-OMON28095MCL (hospital)100
暂停
不适用
SCENTpart 2. Identification of patients with lung cancer and breast cancer.smell-printelectronic Noseexhaled breathlung cancerbreast cancerNL-OMON27863MC300
暂停
不适用
eNose in Head and Neck Cancer.head and neck canceroropharynx carcinomaNL-OMON21851Medical Centre Leeuwarden20
已完成
不适用
Smellprints in lung Cancer; the role of ENose in diagnosis and Treatment (SCENT): part 4. Diagnostic value of the eNose in Head and Neck Cancerhead neck canceroropharyngeal carcinoma100439461003836410029107NL-OMON34633Medisch Centrum Leeuwarden40